Letrozole is a drug, which acts to decrease estrogen levels. A Phase III Study of Tamoxifen vs Toremifene as Adjuvant Therapy for Women with Carcinoma of the Breast. Patients will take either tamoxifen or toremifene orally every day for five years. We affiliate with the Southwest Cancer Center in Lubbock, Texas to offer this breast cancer prevention study. The purpose of the study is to determine whether raloxifene is more or less effective than Tamoxifen in reducing the incidence of invasive breast cancer.
Eligible candidates are postmenopausal women who are at increased risk for breast cancer.
A physician referral is not required.